Latest Dana-Farber Cancer Institute Stories
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.
CANTON, Mass., Aug. 18, 2011 /PRNewswire/ -- Dunkin' Donuts is supporting the Dana-Farber Cancer Institute through the Jimmy Fund for the 13th year to help increase the chances of survival among cancer patients worldwide.
St. Jude Children's Research Hospital scientists lead research that settles a century-old debate about retinoblastoma's beginnings and identify new targets for treating the childhood eye tumor MEMPHIS, Tenn., Aug. 15, 2011 /PRNewswire-USNewswire/ -- A research team led by St.
SOUTH SAN FRANCISCO, Calif. and NORWALK, Conn., Aug. 3, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the Multiple Myeloma Research Foundation (MMRF) today announced the initiation of an expanded access program for carfilzomib, a selective, next-generation proteasome inhibitor.
Salk Institute and Dana Farber Cancer Institute researchers contribute to production of largest-ever map of plant protein interactions.
BOSTON, July 21, 2011 /PRNewswire/ -- Zipcar, Inc. (Nasdaq: ZIP), the world's leading car-sharing network, is taking on the 32nd annual Pan-Massachusetts Challenge (PMC) with a team of 25 riders and a goal of raising $150,000 to support cancer research and treatment.
Promising results of PI3K inhibitor study discussed at ASCO annual meeting SCOTTSDALE, Ariz., July 20, 2011 /PRNewswire-USNewswire/ -- A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G.
Cancer biologists at MIT have identified a new lung cancer gene that drives the spread of the deadly condition.
Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal.
Although it sounds like a case of gender confusion on a molecular scale, the male hormone androgen spurs the growth of some breast tumors in women.
- A trick or prank.